RedHill Biopharma Reports Third Quarter 2019 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to RedHill Biopharma Reports Third Quarter 2019 Financial Results and Operational Highlights

RedHill Biopharma (RDHL) Tops Q3 EPS by 41c

November 19, 2019 7:05 AM EST

RedHill Biopharma (NASDAQ: RDHL) reported Q3 EPS of $0.03, $0.41 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $1.77 million.

Financial highlights for the quarter ended September 30, 2019:

Net Revenues of $1.4 million in the third quarter of 2019, compared to $1.6 million in the second quarter of 2019. Gross Profit of $0.8 million in the third quarter of 2019, compared to $1.1 million in the second quarter of 2019. Research and Development Expenses of $2.8 million in the third quarter of 2019, compared to $7.0 million in the second quarter of 2019.... More